Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
复制标题
小鼠中野生型或突变型 trpc6 的足细胞特异性过度表达足以引起肾小球疾病。
DOI:
10.1371/journal.pone.0012859
复制
发表时间:
2010-09-20
期刊:
影响因子:
3.7
通讯作者:
Walz, Katherina
中科院分区:
文献类型:
--
作者:
Krall, Paola;Canales, Cesar P.;Kairath, Pamela;Carmona-Mora, Paulina;Molina, Jessica;Carpio, J. Daniel;Ruiz, Phillip;Mezzano, Sergio A.;Li, Jing;Wei, Changli;Reiser, Jochen;Young, Juan I.;Walz, Katherina
Mutations in the TRPC6 calcium channel (Transient receptor potential channel 6) gene have been associated with familiar forms of Focal and Segmental Glomerulosclerosis (FSGS) affecting children and adults. In addition, acquired glomerular diseases are associated with increased expression levels of TRPC6. However, the exact role of TRPC6 in the pathogenesis of FSGS remains to be elucidated. In this work we describe the generation and phenotypic characterization of three different transgenic mouse lines with podocyte-specific overexpression of the wild type or any of two mutant forms of Trpc6 (P111Q and E896K) previously related to FSGS. Consistent with the human phenotype a non-nephrotic range of albuminuria was detectable in almost all transgenic lines. The histological analysis demonstrated that the transgenic mice developed a kidney disease similar to human FSGS. Differences of 2–3 folds in the presence of glomerular lesions were found between the non transgenic and transgenic mice expressing Trpc6 in its wild type or mutant forms specifically in podocytes. Electron microscopy of glomerulus from transgenic mice showed extensive podocyte foot process effacement. We conclude that overexpression of Trpc6 (wild type or mutated) in podocytes is sufficient to cause a kidney disease consistent with FSGS. Our results contribute to reinforce the central role of podocytes in the etiology of FSGS. These mice constitute an important new model in which to study future therapies and outcomes of this complex disease.
登录
查看更多内容
影响因子:
3.7
作者:
Heeringa SF;Möller CC;Du J;Yue L;Hinkes B;Chernin G;Vlangos CN;Hoyer PF;Reiser J;Hildebrandt F
通讯作者:
Hildebrandt F
影响因子:
30.8
作者:
Kopp, Jeffrey B.;Smith, Michael W.;Nelson, George W.;Johnson, Randall C.;Freedman, Barry I.;Bowden, Donald W.;Oleksyk, Taras;McKenzie, Louise M.;Kajiyama, Hiroshi;Ahuja, Tejinder S.;Berns, Jeffrey S.;Briggs, William;Cho, Monique E.;Dart, Richard A.;Kimmel, Paul L.;Korbet, Stephen M.;Michel, Donna M.;Mokrzycki, Michele H.;Schelling, Jeffrey R.;Simon, Eric;Trachtman, Howard;Vlahov, David;Winkler, Cheryl A.
通讯作者:
Winkler, Cheryl A.
影响因子:
4.2
作者:
Kajiyama H;Titus S;Austin CP;Chiotos K;Matsumoto T;Sakairi T;Kopp JB
通讯作者:
Kopp JB
DOI:
10.1097/01.asn.0000059864.88610.5e
发表时间:
2003-05-01
影响因子:
13.6
作者:
Michaud, JL;Lemieux, LI;Kennedy, CRJ
通讯作者:
Kennedy, CRJ
影响因子:
5.3
作者:
Donoviel, DB;Freed, DD;Powell, DR
通讯作者:
Powell, DR